TY - JOUR
AU - Mentrup, Torben
AU - Theodorou, Kosta
AU - Cabrera-Cabrera, Florencia
AU - Helbig, Andreas O
AU - Happ, Kathrin
AU - Gijbels, Marion
AU - Gradtke, Ann-Christine
AU - Rabe, Björn
AU - Fukumori, Akio
AU - Steiner, Harald
AU - Tholey, Andreas
AU - Fluhrer, Regina
AU - Donners, Marjo
AU - Schröder, Bernd
TI - Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.
JO - Journal of experimental medicine
VL - 216
IS - 4
SN - 0022-1007
CY - New York, NY
PB - Rockefeller Univ. Press
M1 - DZNE-2020-06933
SP - 807-830
PY - 2019
AB - The lectin-like oxidized LDL receptor 1 (LOX-1) is a key player in the development of atherosclerosis. LOX-1 promotes endothelial activation and dysfunction by mediating uptake of oxidized LDL and inducing pro-atherogenic signaling. However, little is known about modulators of LOX-1-mediated responses. Here, we show that the function of LOX-1 is controlled proteolytically. Ectodomain shedding by the metalloprotease ADAM10 and lysosomal degradation generate membrane-bound N-terminal fragments (NTFs), which we identified as novel substrates of the intramembrane proteases signal peptide peptidase-like 2a and b (SPPL2a/b). SPPL2a/b control cellular LOX-1 NTF levels which, following self-association via their transmembrane domain, can activate MAP kinases in a ligand-independent manner. This leads to an up-regulation of several pro-atherogenic and pro-fibrotic targets including ICAM-1 and the connective tissue growth factor CTGF. Consequently, SPPL2a/b-deficient mice, which accumulate LOX-1 NTFs, develop larger and more advanced atherosclerotic plaques than controls. This identifies intramembrane proteolysis by SPPL2a/b as a novel atheroprotective mechanism via negative regulation of LOX-1 signaling.
KW - ADAM10 Protein: metabolism
KW - Amyloid Precursor Protein Secretases: metabolism
KW - Animals
KW - Aspartic Acid Endopeptidases: antagonists & inhibitors
KW - Aspartic Acid Endopeptidases: genetics
KW - Aspartic Acid Endopeptidases: metabolism
KW - Atherosclerosis: metabolism
KW - Dipeptides: pharmacology
KW - Endothelial Cells: metabolism
KW - HEK293 Cells
KW - HeLa Cells
KW - Humans
KW - Membrane Proteins: genetics
KW - Membrane Proteins: metabolism
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Knockout
KW - Proteolysis
KW - Scavenger Receptors, Class E: genetics
KW - Scavenger Receptors, Class E: metabolism
KW - Transfection
LB - PUB:(DE-HGF)16
C6 - pmid:30819724
C2 - pmc:PMC6446863
DO - DOI:10.1084/jem.20171438
UR - https://pub.dzne.de/record/140611
ER -